Hit Tumors* Hard With TheraSphere
Your patients are fighting for more than their survival. They’re fighting for their quality of life. TheraSphere is uniquely able to help you strike first on both fronts.
Buying Invaluable Time
“If it wasn't for TheraSphere, he wouldn't have enjoyed the quality of his life that he had.” Dr. Kim recalls the inspiring story of an expecting father, a devastating diagnosis, and the two happy years the new dad was able to spend with his son.
1. Salem R, Gabr A, Riaz A, et al. Institutional decision to adopt Y-90 as primary treatment for HCC informed by a 1,000-patient 15-year experience. Hepatology. 2017 Dec 1.
*Refers to HCC or associated tumors